Literature DB >> 16557963

In Vivo and In Vitro Studies of Delayed-Type Hypersensitivity to Toxoplasma gondii in Guinea Pigs.

J L Krahenbuhl1, A A Blazkovec, M G Lysenko.   

Abstract

Delayed-type hypersensitivity develops late in the course of human toxoplasmosis, and a positive skin test is of some value for implicating chronic or eliminating acute forms of toxoplasmosis as a cause of disease. Toxoplasma-infected guinea pigs were studied to determine the onset and development of delayed-type hypersensitivity. Both the toxoplasmin skin test and the in vitro macrophage migration inhibition technique indicated that delayed hypersensitivity to toxoplasma antigen existed as early as 1 week after infection. The mechanism responsible for the observed inhibition of macrophage migration in vitro appeared to be an inhibitory factor(s) released from sensitized lymphoid cells in the presence of antigen.

Entities:  

Year:  1971        PMID: 16557963      PMCID: PMC416141          DOI: 10.1128/iai.3.2.260-267.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

2.  Toxoplasmosis and infectious mononucleosis.

Authors:  J S REMINGTON; C G BARNETT; M MEIKEL; M N LUNDE
Journal:  Arch Intern Med       Date:  1962-11

3.  Ocular toxoplasmosis; pathogenesis, diagnosis and treatment.

Authors:  J K FRENKEL; L JACOBS
Journal:  AMA Arch Ophthalmol       Date:  1958-02

4.  A comparison of the toxoplasmin skin tests, the Sabin-Feldman dye tests, and the complement fixation tests for toxoplasmosis in various forms of uveitis.

Authors:  L JACOBS; H NAQUIN; R HOOVER; A C WOODS
Journal:  Bull Johns Hopkins Hosp       Date:  1956-07

5.  Ocular lesions in hamsters; with chronic Toxoplasma and Besnoitia infection.

Authors:  J K FRENKEL
Journal:  Am J Ophthalmol       Date:  1955-02       Impact factor: 5.258

6.  Human toxoplasma infection.

Authors:  J K BEVERLEY; C P BEATTIE; C ROSEMAN
Journal:  J Hyg (Lond)       Date:  1954-03

7.  Host, strain and treatment variation as factors in the pathogenesis of toxoplasmosis.

Authors:  J K FRENKEL
Journal:  Am J Trop Med Hyg       Date:  1953-05       Impact factor: 2.345

8.  The biology of Toxoplasma.

Authors:  L JACOBS
Journal:  Am J Trop Med Hyg       Date:  1953-05       Impact factor: 2.345

9.  In vitro studies of some immunological phenomena in experimental rabbit toxoplasmosis.

Authors:  G Huldt
Journal:  Acta Pathol Microbiol Scand       Date:  1967

10.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

View more
  5 in total

1.  Effects of immune lymphocyte products and serum antibody on the multiplication of Toxoplasma in murine peritoneal macrophages.

Authors:  T Shirahata; K Shimizu; N Suzuki
Journal:  Z Parasitenkd       Date:  1976-03-31

2.  In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes.

Authors:  J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

3.  Effect of antithymocyte serum on experimental toxoplasmosis in mice.

Authors:  O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

4.  Protective immunity in toxoplasmosis: correlation between antibody response, brain cyst formation, T-cell activation, and survival in normal and B-cell-deficient mice bearing the H-2k haplotype.

Authors:  V Brinkmann; J S Remington; S D Sharma
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J L Krahenbuhl; L Levy; J S Remington
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.